Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 23269595)

1.

Can MRI screen for CSF biomarkers in neurodegenerative disease?

McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M.

Neurology. 2013 Jan 8;80(2):132-8. doi: 10.1212/WNL.0b013e31827b9147. Epub 2012 Dec 26.

2.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Review.

PMID:
22503777
3.

Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers.

Kang JH, Korecka M, Toledo JB, Trojanowski JQ, Shaw LM.

Clin Chem. 2013 Jun;59(6):903-16. doi: 10.1373/clinchem.2013.202937. Epub 2013 Mar 21. Review.

4.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Epub 2010 Jul 22. Review.

5.

Biological markers of Alzheimer's disease.

de Souza LC, Sarazin M, Teixeira-Júnior AL, Caramelli P, Santos AE, Dubois B.

Arq Neuropsiquiatr. 2014 Mar;72(3):227-31. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk